Theralase Technologies Inc. V.TLT

Theralase's ACT doesn't need to be the cure for cancer

[Eoganacht]

In a recent interview Roger said:

"The latest data that Theralase has put out - we had a 66 complete response rate at any point in time with 33 at 15 months. So dramatically higher than what's already been approved. So we think it bodes well for the future of the company. And it bodes well for value of the organization. Hopefully it bodes well for the shareholders and the stakeholders in the company as well."

Halfway through the phase 2, TLD1433 PDT has proven itself to be a better solution than the approved treatments for BCG-unresponsive NMIBC in terms of safety, efficacy and number of treatments.

15 month CR rates could be 10% or more higher by the end of the trial (43%+  CR).

I think there is no doubt whatsoever that TLD1433 PDT will benefit bladder cancer patients with very little down side and will be a valuable addition to the anti-cancer tools available.

And that should be all that is needed for BTD, AA and a dramatic rise in the stock price. Big pharmas should be tripping over each other to acquire Theralase.

I don't get why this is not happening. 

In the current trial TLD1433 PDT is being used on the most difficult to treat kind of NMIBC - high-grade BCG-unresponsive NMIBC with or without CIS. If it proves itself in this trial it could go head to head against BCG as a first line treatment and also be trialed for MIBC.

TLD1433 PDT could end up benefiting patients with all the varieties of bladder cancer - as a standalone treatment and/or an adjunct to other treatments.

And if it works with bladder cancer, there is a high probability it could be adapted for use against NSCLC, GBM, melanoma, colon, breast, pancreatis, esophageal etc. It doesn't have to totally cure any of these cancer types - just be of benefit to the patient - destroy tumours, or just shrink them and encourage the patient's own immune system to kick in.

And there is all the other research of Dr. McFarland waiting in the wings. All of the more potent ruthenium and osmium based photosensitizers that Theralase has rights to.

So why are we sitting at 27 cents with no money in the till?

[BlueFranky]

Good post eog.. count me In on the question you just raised The question I ask: Does Theralase have the goods already in hand, statistically speaking, to merit both BTD and AA simultaneously ... And are deals being sealed in the back rooms based on that possibility.. waiting in the wings for the fda's announcement accordingly? Because the facts are - we are superior to all comers, even at

[N0taP00p]

Very well said! It just doesn't make sense. Hopefully, just a matter of weeks. 

[skys1]

Great post Eoganacht !!! The fact that several members of the Big Pharma community havn't already made a move on TLT is very surpriseing considering it is head & sholders it's competition. All will happen in due time.  

[Legit62]

Skys1 i agree, i feel the BTD and AA takes the risk out IMO

[skys1]

Agree Legit, After BTD & AA, a bidding war could ensue. 

[ggrellette]

Designations will definitely open many eyes and investors wallets. The biggest event those designations will do is bring big pharmas to the table. Yep JV partnerships. We all know when that will happen is when the volume suddenly increases substantially. 

[Legit62]

Eog, i think its the exchange we are on and manipulation being played plus EXTREMELY low share volume, once we get BTD and AA i honestly believe we cross the barrier of keeping this down, hope soon after we get a JV or buyout, got to remember Roger has been at this for a long time and im sure he wants a big payout while he still has some good years in him, plus the notoriety that goes along with